These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3910776)

  • 1. Decision-making in the development of new drugs.
    Breckenridge A
    J Hypertens Suppl; 1985 Nov; 3(2):S51-5. PubMed ID: 3910776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
    Lipicky R
    J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
    Messerli FH; Michalewicz L
    J Hypertens Suppl; 1998 Jan; 16(1):S81-4. PubMed ID: 9534103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical assessment of international clinical development programmes for new antihypertensive drugs.
    Ménard J
    J Hypertens Suppl; 1993 Dec; 11(5):S39-46. PubMed ID: 8158432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the Lannett and Pharmadyne decisions.
    Vetrano AJ
    Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic controversies in hypertension.
    Messerli FH; Grossman E
    Semin Nephrol; 2005 Jul; 25(4):227-35. PubMed ID: 16202695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of antihypertensive therapy.
    Taylor AA; Pool JL
    Semin Nephrol; 2005 Jul; 25(4):215-26. PubMed ID: 16202694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized drugs: current regulatory perspective.
    Chew N
    Respir Care; 2000 Jun; 45(6):764-8. PubMed ID: 10894466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 17. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for drug therapy in hypertension.
    McNally P
    Int J Clin Pract; 2001; 55(1):32-40. PubMed ID: 11219316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The great American medicine show revisited.
    Tomes N
    Bull Hist Med; 2005; 79(4):627-63. PubMed ID: 16327082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging drug treatments for hypertension.
    Krum H; Pellizzer AM
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.